Fundraising Fox

Antoine Boulanger

Investor

Partner at Apollo Health Ventures

France

About

Antoine Boulanger joined Apollo Health Ventures as a Partner in 2025. He was previously a Principal at Forbion, where he sourced and managed biotech and therapeutics investments, and he began his career in life sciences equity research and venture capital, including due diligence work at BDC's Healthcare Venture Fund in Canada. He holds a Ph.D. in Molecular Medicine from Laval University, with published research in muscle physiology and neuromuscular disease.

LinkedIn ↗

Invests in

Biotech

Experience

  1. Apollo Health VenturesPartnercurrent2025 — present
  2. ForbionPrincipal2024 — 2025Naarden, North Holland, Netherlands
  3. ForbionSenior Associate2022 — 2024
  4. ForbionAssociate2020 — 2022Naarden, Netherlands
  5. ForbionAnalyst2019 — 2020Naarden, Netherlands
  6. BDCHealthcare Venture Fund - Venture Capital2017Région de Montréal, Canada

Education

  1. Université LavalDoctor of Philosophy (Ph.D.), Molecular Medicine
  2. The Wharton SchoolBusiness Foundations Specialization Certificate2015
  3. Université LavalMaster of Science (M.Sc.), Molecular Medicine2013 — 2014
  4. Université LavalBachelor of Science (B.Sc.), Biology2010 — 2012

Skills & more

Molecular Medicine27Entrepreneurship27Skeletal muscle physiology21Physiology18Pharmaceutical Industry17Strategy14Mergers & Acquisitions11Finance11Venture Capital11Start-ups16

From Antoine's professional profile.

Same school

Also attended Université Laval31

Laura WeigertSenior Associate at Marlin Equity PartnersLeah BaePrincipal at Higher Ground LabsDylan Lawrence MissonnierInvestment Director at CapagroWenceslas MoussaHead of Risk & Compliance at HeadlineChris ArsenaultFounder and Partner at Inovia CapitalSophie GuptaPrincipal at Yaletown Partners

+ 25 more

Also attended The Wharton School1,372

Fred WilsonCo-founder & Partner at Union Square VenturesJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General CatalystRebecca JamesInvestor at Index Ventures

+ 1,366 more

Shared employers

Also worked at Forbion22

Christina TakkeManaging Partner at V-Bio VenturesMathias FalcenbergVenture Partner at V-Bio VenturesIvan BurkovJunior Partner at InkefAnne Marije van HartenInvestment Director at Apollo Health VenturesRobbert van de GriendtHead of Investment Relations at BioGeneration VenturesDirk KerstenManaging Partner at Forbion

+ 16 more

Also worked at BDC59

Inshaal QadirAnalyst at Panache VenturesAlex McIsaacGeneral Partner at Inovia CapitalMark TrevittFounder & Managing Partner at Inovia CapitalRobert SimonVenture Partner at Ridge VenturesSabreen SidhuSenior Analyst at Vistara GrowthJoshuah LebacqPrincipal at NAventures

+ 53 more

Investments

Led

Versanis Bio

Board seats

Armgo PharmaAzafarosCalluna PharmaDyne TherapeuticsInversago PharmaMestag TherapeuticsRectify Pharma

Per the firm's website.

Colleagues at Apollo Health Ventures

Alex Strasser
Senior Associate at Apollo Health Ventures
Alexandra Bause
Co-Founder and Venture Partner at Apollo Health Ventures
Anela Vukoja
COO at Apollo Health Ventures
Anne Marije van Harten
Investment Director at Apollo Health Ventures
Christopher R. Shepard
Venture Partner at Apollo Health Ventures
Dr. Alexandra Bause
Co-Founder & Venture Partner at Apollo Health Ventures
Dr. Gerd Hummel
Venture Partner at Apollo Health Ventures
Dr. Jeanne Bolger
Advisor at Apollo Health Ventures